This inventor holds 28 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Glycobiology Innovations. Top assignee: New England Biolabs, Inc.. Active years: 1994-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Marblehead, MA (US) (1994)
- Beverly Farms, MA (US) (2005)
- Champaign, IL (US) (1998 - 2006)
- Essex, MA (US) (2006 - 2023)
Company Filing History:
Years Active: 1994-2025
Areas of Expertise:
Title: **Christopher H. Taron: Innovating mRNA Capping Enzymes**
Introduction
Christopher H. Taron, based in Essex, MA, is a distinguished inventor with an impressive portfolio of 27 patents. His innovative work primarily focuses on mRNA capping enzymes, which play a crucial role in the development of RNA vaccines. Through his inventions, Taron contributes significantly to the advancement of biotechnology and therapeutic applications.
Latest Patents
Among Taron's latest groundbreaking patents are compositions, methods, and kits related to FCE mRNA capping enzyme. This invention involves creating RNA vaccines that possess an appropriate cap structure, enhancing stability and effectiveness. The patent discusses systems and methods that utilize non-naturally occurring single-chain RNA capping enzymes, including FCE variants with specific amino acid sequence modifications.
Another notable patent by Taron pertains to vaccinia capping enzyme compositions and methods. This invention outlines methods for producing active heterodimers of vaccinia capping enzyme, comprising D1 and D12 subunits. The technology discussed allows for the fusion of these proteins, which may contain linkers, thus enhancing their functionality in various applications.
Career Highlights
Christopher H. Taron's career is marked by his role at New England Biolabs, Inc., where he collaborates on significant projects related to RNA technology and vaccine development. His expertise in molecular biology and enzymology has enabled him to make impactful contributions to the field, solidifying his reputation as a leading inventor in the biotechnology sector.
Collaborations
Throughout his career, Taron has collaborated with esteemed colleagues, including Paul A. Colussi and Mehul Ganatra. These partnerships highlight his ability to work effectively within teams, driving forward innovations that can change the landscape of biopharmaceutical development.
Conclusion
In conclusion, Christopher H. Taron exemplifies the spirit of innovation in the biotechnology field with his extensive patent portfolio and pivotal contributions to mRNA capping enzyme technology. His work has the potential to make significant strides in the development of effective RNA vaccines, reinforcing the importance of collaboration among inventors and research institutions in driving scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile